Pancreatic Beta-Cell Protection Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Pancreatic ? cells function as glucose sensors and control GSIS. Insulin from pancreatic ? cells inhibits gluconeogenesis and induces glycogen synthesis in the liver, which is the important organ in controlling blood glucose. Beta cells (? cells) are a type of cell found in pancreatic islets that synthesize and secrete insulin and amylin. Beta cells make up 50–70% of the cells in human islets. In patients with type I or type II diabetes, beta-cell mass and function are diminished, leading to insufficient insulin secretion and hyperglycemia.
MARKET DYNAMICS
The pancreatic beta-cell protection market is driving due to the growing prevalence of chronic diseases and rising diabetic patients. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research boost the market growth in the forecast period.
MARKET SCOPE
The "Pancreatic Beta-Cell Protection Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pancreatic beta-cell protection market with detailed market segmentation by product and application. The pancreatic beta-cell protection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pancreatic beta-cell protection market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pancreatic beta-cell protection market is segmented on the basis of product and application. Based on product, the market is segmented as stem cell based, gene therapies, RNA based therapies, monoclonal antibodies (mabs) and phytotherapy. On the basis of application, the market is categorized as hospital, medical research laboratory and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pancreatic beta-cell protection market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pancreatic beta-cell protection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pancreatic beta-cell protection market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pancreatic beta-cell protection market in these regions.
![World Geography](https://www.theinsightpartners.com/assets/rdimages/world-geography.png)
Have a question?
![Analyst](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pancreatic beta-cell protection market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pancreatic beta-cell protection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pancreatic beta-cell protection market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pancreatic beta-cell protection market in these regions.
MARKET PLAYERS
The report covers key developments in the pancreatic beta-cell protection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pancreatic beta-cell protection market are anticipated to have lucrative growth opportunities in the future with the rising demand for pancreatic beta-cell protection in the global market. Below mentioned is the list of few companies engaged in the pancreatic beta-cell protection market.
The report also includes the profiles of key players in pancreatic beta-cell protection market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Beta-Cell NV
- Beta-O2 Technologies Ltd
- BioLineRx
- Boehringer Ingelheim
- GalaxoSmithKline
- Genentech
- Janssen Research and Development
- Novartis
- Novo Nordisk
- Pfizer Inc
- Sanofi
- Transition Therapeutics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pancreatic Beta-Cell Protection Market - By Product
1.3.2 Pancreatic Beta-Cell Protection Market - By Applications
1.3.3 Pancreatic Beta-Cell Protection Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PANCREATIC BETA-CELL PROTECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PANCREATIC BETA-CELL PROTECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PANCREATIC BETA-CELL PROTECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. PANCREATIC BETA-CELL PROTECTION - GLOBAL MARKET OVERVIEW
6.2. PANCREATIC BETA-CELL PROTECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PANCREATIC BETA-CELL PROTECTION MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. STEM CELL BASED
7.3.1. Overview
7.3.2. Stem Cell Based Market Forecast and Analysis
7.4. GENE THERAPIES
7.4.1. Overview
7.4.2. Gene Therapies Market Forecast and Analysis
7.5. RNA BASED THERAPIES
7.5.1. Overview
7.5.2. RNA Based Therapies Market Forecast and Analysis
7.6. MONOCLONAL ANTIBODIES (MABS)
7.6.1. Overview
7.6.2. Monoclonal Antibodies (MAbs) Market Forecast and Analysis
7.7. PHYTOTHERAPY
7.7.1. Overview
7.7.2. Phytotherapy Market Forecast and Analysis
8. PANCREATIC BETA-CELL PROTECTION MARKET - REVENUE AND FORECASTS TO 2028 – APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. MEDICAL RESEARCH LABORATORY
8.4.1. Overview
8.4.2. Medical Research Laboratory Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. PANCREATIC BETA-CELL PROTECTION MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pancreatic Beta-Cell Protection Market Overview
9.1.2 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.1.3 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.1.4 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.1.5 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pancreatic Beta-Cell Protection Market
9.1.5.1.1 United States Pancreatic Beta-Cell Protection Market by Product
9.1.5.1.2 United States Pancreatic Beta-Cell Protection Market by Applications
9.1.5.2 Canada Pancreatic Beta-Cell Protection Market
9.1.5.2.1 Canada Pancreatic Beta-Cell Protection Market by Product
9.1.5.2.2 Canada Pancreatic Beta-Cell Protection Market by Applications
9.1.5.3 Mexico Pancreatic Beta-Cell Protection Market
9.1.5.3.1 Mexico Pancreatic Beta-Cell Protection Market by Product
9.1.5.3.2 Mexico Pancreatic Beta-Cell Protection Market by Applications
9.2. EUROPE
9.2.1 Europe Pancreatic Beta-Cell Protection Market Overview
9.2.2 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.2.3 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.2.4 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.2.5 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pancreatic Beta-Cell Protection Market
9.2.5.1.1 Germany Pancreatic Beta-Cell Protection Market by Product
9.2.5.1.2 Germany Pancreatic Beta-Cell Protection Market by Applications
9.2.5.2 France Pancreatic Beta-Cell Protection Market
9.2.5.2.1 France Pancreatic Beta-Cell Protection Market by Product
9.2.5.2.2 France Pancreatic Beta-Cell Protection Market by Applications
9.2.5.3 Italy Pancreatic Beta-Cell Protection Market
9.2.5.3.1 Italy Pancreatic Beta-Cell Protection Market by Product
9.2.5.3.2 Italy Pancreatic Beta-Cell Protection Market by Applications
9.2.5.4 Spain Pancreatic Beta-Cell Protection Market
9.2.5.4.1 Spain Pancreatic Beta-Cell Protection Market by Product
9.2.5.4.2 Spain Pancreatic Beta-Cell Protection Market by Applications
9.2.5.5 United Kingdom Pancreatic Beta-Cell Protection Market
9.2.5.5.1 United Kingdom Pancreatic Beta-Cell Protection Market by Product
9.2.5.5.2 United Kingdom Pancreatic Beta-Cell Protection Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Overview
9.3.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.3.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pancreatic Beta-Cell Protection Market
9.3.5.1.1 Australia Pancreatic Beta-Cell Protection Market by Product
9.3.5.1.2 Australia Pancreatic Beta-Cell Protection Market by Applications
9.3.5.2 China Pancreatic Beta-Cell Protection Market
9.3.5.2.1 China Pancreatic Beta-Cell Protection Market by Product
9.3.5.2.2 China Pancreatic Beta-Cell Protection Market by Applications
9.3.5.3 India Pancreatic Beta-Cell Protection Market
9.3.5.3.1 India Pancreatic Beta-Cell Protection Market by Product
9.3.5.3.2 India Pancreatic Beta-Cell Protection Market by Applications
9.3.5.4 Japan Pancreatic Beta-Cell Protection Market
9.3.5.4.1 Japan Pancreatic Beta-Cell Protection Market by Product
9.3.5.4.2 Japan Pancreatic Beta-Cell Protection Market by Applications
9.3.5.5 South Korea Pancreatic Beta-Cell Protection Market
9.3.5.5.1 South Korea Pancreatic Beta-Cell Protection Market by Product
9.3.5.5.2 South Korea Pancreatic Beta-Cell Protection Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pancreatic Beta-Cell Protection Market Overview
9.4.2 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.4.3 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pancreatic Beta-Cell Protection Market
9.4.5.1.1 South Africa Pancreatic Beta-Cell Protection Market by Product
9.4.5.1.2 South Africa Pancreatic Beta-Cell Protection Market by Applications
9.4.5.2 Saudi Arabia Pancreatic Beta-Cell Protection Market
9.4.5.2.1 Saudi Arabia Pancreatic Beta-Cell Protection Market by Product
9.4.5.2.2 Saudi Arabia Pancreatic Beta-Cell Protection Market by Applications
9.4.5.3 U.A.E Pancreatic Beta-Cell Protection Market
9.4.5.3.1 U.A.E Pancreatic Beta-Cell Protection Market by Product
9.4.5.3.2 U.A.E Pancreatic Beta-Cell Protection Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pancreatic Beta-Cell Protection Market Overview
9.5.2 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.5.3 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.5.4 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pancreatic Beta-Cell Protection Market
9.5.5.1.1 Brazil Pancreatic Beta-Cell Protection Market by Product
9.5.5.1.2 Brazil Pancreatic Beta-Cell Protection Market by Applications
9.5.5.2 Argentina Pancreatic Beta-Cell Protection Market
9.5.5.2.1 Argentina Pancreatic Beta-Cell Protection Market by Product
9.5.5.2.2 Argentina Pancreatic Beta-Cell Protection Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PANCREATIC BETA-CELL PROTECTION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PANCREATIC BETA-CELL PROTECTION MARKET, KEY COMPANY PROFILES
12.1. BETA-CELL NV
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BETA-O2 TECHNOLOGIES LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOLINERX
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GALAXOSMITHKLINE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GENENTECH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN RESEARCH AND DEVELOPMENT
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVO NORDISK
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PFIZER INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. SANOFI
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. TRANSITION THERAPEUTICS
12.12.1. Key Facts
12.12.2. Business Description
12.12.3. Products and Services
12.12.4. Financial Overview
12.12.5. SWOT Analysis
12.12.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Beta-Cell NV
2. Beta-O2 Technologies Ltd
3. BioLineRx
4. Boehringer Ingelheim
5. GalaxoSmithKline
6. Genentech
7. Janssen Research and Development
8. Novartis
9. Novo Nordisk
10. Pfizer Inc
11. Sanofi
12. Transition Therapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.